By Anas Abbas
The Nigeria Centre for Disease Control and Prevention (NCDC) revealed that between 2023 and 2024, Cerebrospinal Meningitis (CSM) claimed the lives of 361 individuals across 24 states, including the Federal Capital Territory (FCT)Abuja.
During an update on the ongoing Lassa fever and meningitis outbreaks, Dr Jide Idris, the Director General of NCDC, highlighted that these fatalities were recorded in 174 Local Government Areas (LGAs) nationwide. Additionally, the country has seen 4,915 suspected cases and 380 confirmed cases of CSM during the same period.
Cerebrospinal Meningitis is characterised by acute inflammation of the protective membranes surrounding the brain and spinal cord.
This inflammation can result from various infectious agents, including bacteria, viruses, parasites, and fungi, as well as from injuries or certain medications.
Dr. Idris emphasised that CSM is an epidemic-prone disease with year-round cases reported in Nigeria. He noted that environmental factors, particularly during the dry season marked by dust storms, cold nights, and increased respiratory infections, heighten the risk of infection, especially in overcrowded and poorly ventilated settings.
The “Meningitis Belt,” which encompasses all 19 northern states, the FCT, and parts of southern states such as Bayelsa, Cross River, Delta, Ekiti, Ogun, Ondo, and Osun, bears the highest burden of CSM in Nigeria.
In response to this public health challenge, over 2.28 million Men5CV-ACWYX meningitis vaccines have been administered in Bauchi, Gombe, and Jigawa across 134 wards in 13 LGAs.
The vaccination campaign primarily targets individuals aged 1 to 29, representing approximately 70% of the population.
Dr. Idris concluded that despite recent advancements in surveillance, diagnostic capabilities, and vaccination efforts, CSM remains a critical public health concern in Nigeria. Due to its recurrent outbreaks in high-burden states, the disease continues to pose challenges for individuals, health systems, economies, and communities.